| # | Drug | Count |
|---|---|---|
| 0 | CAPLACIZUMAB | 73 |
| 1 | ECULIZUMAB | 10 |
| 2 | PREDNISONE | 4 |
| 3 | RITUXIMAB | 4 |
| 4 | LINEZOLID | 2 |
| 5 | AMLODIPINE | 1 |
| 6 | ARNICA MONTANA, HYPERICUM PERFORATUM, LEDUM PALUSTRE, MORBILLINUM, NATRUM MURIATICUM, SILICEA, SULPHUR IODATUM, THUJA OCCIDENTALIS, URTICA URENS | 1 |
| 7 | BORTEZOMIB | 1 |
| 8 | BOSENTAN | 1 |
| 9 | CARVEDILOL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPLACIZUMAB | 73 | 0.0409 |
| 1 | ARNICA MONTANA, HYPERICUM PERFORATUM, LEDUM PALUSTRE, MORBILLINUM, NATRUM MURIATICUM, SILICEA, SULPHUR IODATUM, THUJA OCCIDENTALIS, URTICA URENS | 1 | 0.0047 |
| 2 | VANDETANIB | 1 | 0.0006 |
| 3 | LETERMOVIR | 1 | 0.0003 |
| 4 | ECULIZUMAB | 10 | 0.0002 |
| 5 | GLYCOPYRROLATE | 1 | 0.0002 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 7 | GANCICLOVIR SODIUM | 1 | 0.0001 |
| 8 | EPOETIN ALFA | 1 | 0.0001 |
| 9 | SUVOREXANT | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 1 | Complement Inhibitor [EPC] | 10 | 0.0002 |
| 2 | Oxazolidinone Antibacterial [EPC] | 2 | 0.0001 |
| 3 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 4 | 0.0000 |
| 7 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 8 | Anti-IgE [EPC] | 1 | 0.0000 |
| 9 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |